siRNA therapy lowers triglycerides in clients with uncommon ailment

.RESEARCH STUDY HIGHLIGHT.19 September 2024.

Plozasiran lessened triglyceride amounts by 80% as well as decreased the threat of pancreatitis in patients with chronic chylomicronemia, along with or without a hereditary diagnosis.